President Donald Trump is considering whether to cut off funding to the World Health Organization; relief for the public amid the coronavirus disease 2019 (COVID-19) pandemic remains stagnant as Republicans and Democrats have yet to agree on a new stimulus bill; no spike in COVID-19 cases has been observed so far in reopened states.
According to administration officials, President Donald Trump is again considering cutting off funding to the World Health Organization (WHO), signaling a potential shift away from prior plans to restore partial funding, according to The Wall Street Journal. Although officials said Trump has yet to make a final decision, he has grown skeptical of an internal proposal that would provide reduced funding to WHO aligned with China’s contributions. The move follows a resolution agreed to by more than 100 countries, which will independently review whether WHO acted to the best of its abilities to contain the spread of coronavirus disease 2019 (COVID-19).
As Americans await the next round of COVID-19 relief funding, an article posted by POLITICO indicates that the next relief checks will most likely take weeks, if not longer. There is currently no bipartisan talk among congressional leaders on a $3 trillion stimulus bill formed by House Democrats this past Friday that would provide aid for local governments and to the public. The Republican Senate has no plans to provide an alternative plan and will instead consider judicial appointments this week before heading home for the Memorial Day recess.
HHS Secretary Alex Azar said yesterday that there have been no observed spikes in COVID-19 cases among states that are easing social distancing restrictions and reopening, but he cautions that it is still too early to determine resulting trends. Reported by Reuters, Azar notes that identifying and reporting new cases takes time and that vital trends to monitor include the surveillance of flu-like symptoms in the population and other hospital admissions data. According to a Reuters analysis, nearly all 50 states have started allowing businesses to reopen and eased restrictions for residents, with only 14 states meeting the federal government’s guidelines for lifting measures amid the pandemic.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More